Breast Cancer Research and Treatment

, Volume 22, Issue 3, pp 207–219

The Nottingham prognostic index in primary breast cancer

  • Marcus H. Galea
  • Roger W. Blamey
  • Christopher E. Elston
  • Ian O. Ellis
Article

Summary

In 1982 we constructed a prognostic index for patients with primary, operable breast cancer. This index was based on a retrospective analysis of 9 factors in 387 patients. Only 3 of the factors (tumour size, stage of disease, and tumour grade) remained significant on multivariate analysis. The index was subsequently validated in a prospective study of 320 patients. We now present the results of applying this prognostic index to all of the first 1,629 patients in our series of operable breast cancer up to the age of 70. We have used the index to define three subsets of patients with different chances of dying from breast cancer: 1) good prognosis, comprising 29% of patients with 80% 15-year survival; 2) moderate prognosis, 54% of patients with 42% 15-year survival; 3) poor prognosis, 17% of patients with 13% 15-year survival. The 15-year survival of an age-matched female population was 83%.

Key words

histologic grade micrometastases in nodes morphometry nodal stage prognostic index tumour size vascular-lymphatic invasion 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Handley WS: Cancer of the Breast and its Treatment (2nd Edition). John Murray, London, 1922Google Scholar
  2. 2.
    Berstock DA, Houghton J, Haybittle J, Baum M: The role of radiotherapy following total mastectomy for patients with early breast cancer. World J Surg 9:667–670, 1985Google Scholar
  3. 3.
    Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham L, Deutsch M, Montague E, Morgolese R, Foster R: Ten year results of a randomised clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674–681, 1985Google Scholar
  4. 4.
    Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K: A prognostic index in primary breast cancer. Br J Cancer 45:361–366, 1982Google Scholar
  5. 5.
    Blamey RW, Davies CJ, Elston CW, Johnson J, Haybittle JL, Maynard PV: Prognostic factors in breast cancer — the formation of a prognostic index. Clin Oncol 5:227–236, 1979Google Scholar
  6. 6.
    Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long term follow-up. Histopathology 19:403–410, 1991Google Scholar
  7. 7.
    Todd JH, Dowle C, Williams MR, Elston CW, Ellis IO, Hinton CP, Blamey RW, Haybittle JL: Confirmation of a prognostic index in primary breast cancer. Br J Cancer 56:489–492, 1987Google Scholar
  8. 8.
    Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immunotherapy. Lancet 339:1–15 & 71–84, 1992Google Scholar
  9. 9.
    Williams MR, Todd JH, Ellis IO, Dowle CS, Haybittle JL, Elston CW, Nicholson RI, Griffiths K, Blamey RW: Oestrogen receptors in primary and advanced breast cancer: An eight year review of 704 cases. Br J Cancer 55:67–73, 1987Google Scholar
  10. 10.
    Fisher B, Slack NH, Bross IDJ, and cooperating investigators: Cancer of the breast: Size of neoplasm and prognosis. Cancer 24:1071–1080, 1969Google Scholar
  11. 11.
    Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP: Management and survival of female breast cancer: Results of a national survey by the American College of Surgeons. Cancer 45:2917–2924, 1980Google Scholar
  12. 12.
    Carter CL, Allen C, Henson DE: Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181–187, 1989Google Scholar
  13. 13.
    Fisher B, Ravdin RG, Ausman RK, Slack NH, Moore GE, Noer RJ, and cooperating investigators: Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of cooperative investigation. Ann Surg 168:337–356, 1968Google Scholar
  14. 14.
    Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41:1170–1178, 1978Google Scholar
  15. 15.
    Fisher B, Bauer M, Wickerham L, Redmond CK, Fisher ER (with the contribution of others): Relation of number of positive axillary nodes to the prognosis of patients with breast cancer: An NSABP update. Cancer 52:1551–1557, 1983Google Scholar
  16. 16.
    Adair FE: Surgical problems involved in breast cancer. Ann Roy Coll Surg Engl 4:360–380, 1949Google Scholar
  17. 17.
    Berg JW: The significance of axillary node levels in the study of breast carcinomas. Cancer 8:776–778, 1955Google Scholar
  18. 18.
    Adair F, Berg J, Joubert L, Robbins GF: Long term follow up of breast cancer patients: The 30 year report. Cancer 33:1145–1150, 1974Google Scholar
  19. 19.
    Smith JA, Gamez-Aranjo JJ, Gallager HS, White EC, McBride CM: Carcinoma of the breast: Analysis of total lymph node involvement versus level of metastases. Cancer 39:527–532, 1977Google Scholar
  20. 20.
    Barth RJ, Danforth DN, Venzon DJ, Straus KL, d'Angelo T, Merino MJ, Gerber L: Level of axillary involvement of lymph node metastases from breast cancer is not an independent predictor of survival. Arch Surg 126:574–577, 1991Google Scholar
  21. 21.
    du Toit R, Locker AP, Ellis IO, Elston CW, Blamey RW: Evaluation of the prognostic value of triple node biopsy in early breast cancer. Br J Surg 77:163–167, 1990Google Scholar
  22. 22.
    Wolff B: Histological grading in carcinoma of the breast. Br J Cancer 20:36–40, 1966Google Scholar
  23. 23.
    Tough ICK, Carter DC, Fraser J, Bruce J: Histological grading in breast cancer. Br J Cancer 23:294–301, 1969Google Scholar
  24. 24.
    Parl FF, Dupont WD: A retrospective cohort study of histologic risk factors in breast cancer patients. Cancer 50:2410–2416, 1982Google Scholar
  25. 25.
    Fisher ER, Sass R, Fisher B: Pathologic findings from the NSABP (Protocol No. 4). X. Discriminants for tenth year treatment failure. Cancer 53:712–723, 1984Google Scholar
  26. 26.
    Champion HR, Wallace IWJ, Prescott RJ: Histology in breast cancer prognosis. Br J Cancer 26:129–138, 1972Google Scholar
  27. 27.
    Contesso G, Mouriesse H, Friedman S, Genin G, Sarrazin D, Rouesse J: The importance of histologic grade in long-term prognosis for breast cancer: A study of 1010 patients uniformly treated at the Institut Gustave-Roussy. J Clin Oncol 5:1378–1386, 1987Google Scholar
  28. 28.
    Stenkvist B, Westman-Naeser S, Vegelius J, Holmquist J, Nordin B, Bengtsson E, Eriksson O: Analysis of reproducibility of subjective grading systems for breast carcinoma. J Clin Pathol 32:979–985, 1979Google Scholar
  29. 29.
    Delides GS, Garas G, Georgouli G, Jiortziotis D, Lecca J, Liva T, Elemenoglou J: Intralaboratory variations in the grading of breast carcinoma. Arch Pathol Lab Med 106:126–128, 1982Google Scholar
  30. 30.
    Gilchrist KW, Kalish L, Gould VE, Hirschl S, Imbriglie JE, Levy HM, Patchefsky AS, Penner DW, Pickren J, Roth JA, Schinella RA, Schwartz IS, Wheeler JE: Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study. Breast Cancer Res Treat 5:3–10, 1985Google Scholar
  31. 31.
    Chetty U: Axillary surgery in breast cancer. 5th Breast Cancer Working Conference, Belgium, 1991Google Scholar
  32. 32.
    Wells CA, Heryet A, Brochier J, Gatter KC, Mason DY: The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer 50:193–197, 1984Google Scholar
  33. 33.
    Trojanio M, de Mascarel I, Bonichon F, Coindre JM, Delsol G: Micrometastases to axillary lymph nodes from carcinoma of the breast: Detection by immunochemistry and prognostic significance. Br J Cancer 55:303–306, 1987Google Scholar
  34. 34.
    Friedman S, Bertin F, Mouriesse H, Benchabat A, Genin J, Sarrazin D, Contesso G: Importance of tumour cells in axillary node sinus margins (‘clandestine’ metastases) discovered by serial sectioning in operable breast cancer. Acta Oncol 27:483–487, 1988Google Scholar
  35. 35.
    International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 335:1565–1568, 1990Google Scholar
  36. 36.
    Huvos AG, Hutter RVP, Berg JW: Significance of axillary macrometastasis and micrometastases in mammary cancer. Ann Surg 173:44–46, 1971Google Scholar
  37. 37.
    Fisher ER, Palekar A, Rochette H, Redmond C, Fisher B: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases. Cancer 42:2032–2038, 1978Google Scholar
  38. 38.
    Galea MH, Athanassiou E, Bell J, Dilks B, Robertson JFR, Elston CW, Blamey RW, Ellis IO: Occult regional lymph node metastases from breast carcinoma: Immunohistological detection with antibodies CAM 5.2 and NCRC-11. J Pathol 165:221–227, 1991Google Scholar
  39. 39.
    Sampat MB, Sirsat MV, Gangadharan P: Prognostic significance of blood vessel invasion in carcinoma of the breast in women. J Surg Oncol 9:623–632, 1977Google Scholar
  40. 40.
    Wiegand RA, Isenberg MW, Russo J, Brennan MJ, Rich MA, and the Breast Cancer Prognostic Study Associates: Blood vessel invasion and axillary node involvement as prognostic indicators to human breast cancer. Cancer 50:962–969, 1982Google Scholar
  41. 41.
    Lee AKC, DeLellis RA, Silverman ML, Heattey GJ, Wolfe HJ: Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol 8:1457–1465, 1990Google Scholar
  42. 42.
    O'Rourke S, Galea MH, Euhas E, Pinder S, Ellis IO, Elston CW, Blamey RW: An audit of local recurrence following simple mastectomy. Br J Surg 1991, in pressGoogle Scholar
  43. 43.
    Locker AP, Ellis IO, Morgan DAL, Elston CW, Mitchell A, Blamey RW: Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 76:890–894, 1989Google Scholar
  44. 44.
    Fourquet A, Campana F, Zafrani B, Mossen V, Vieth P, Durand JC, Vilcoq JR: Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25 year follow-up. Int J Rad Biol Phys 17:719–725, 1988Google Scholar
  45. 45.
    Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW: II. Histological type. Relationship with survival in a large study with long term follow-up. Histopathology 1992, in pressGoogle Scholar
  46. 46.
    Ellis IO, Bell J, Todd J, Williams M, Dowle C, Robins AR, Elston CW, Blamey RW, Baldwin RW: Evaluation of immunoreactivity with monoclonal antibody NCRC-11 in breast carcinoma. Br J Cancer 56:295–299, 1987Google Scholar
  47. 47.
    Dowle CS, Owainati A, Robins A, Burns K, Ellis IO, Elston CW, Blamey RW: The prognostic significance of the DNA content of human breast cancer. Br J Surg 74:133–136, 1987Google Scholar
  48. 48.
    Lovekin A, Ellis IO, Locker AP, Robertson JFR, Bell J, Nicholson R, Gullick WJ, Elston CW, Blamey RW: c-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer 63:439–443, 1991Google Scholar
  49. 49.
    Locker AP, Dowle CS, Ellis IO, Elston CW, Blamey RW, Sikora K, Evan G, Robins RA: C-myc oncogene product expression and prognosis in operable breast cancer. Br J Cancer 60:669–672, 1989Google Scholar
  50. 50.
    Fenlon S, Ellis IO, Bell J, Todd J, Elston CW, Blamey RW:Helix pomatia andUlex europeus lectin binding in human breast carcinoma. J Pathol 152:169–176, 1987Google Scholar
  51. 51.
    Chevallier B, Mossen V, Dauce JP, Bastit P, Julien JP, Asselain B: A prognostic score in histological node negative breast cancer. Br J Cancer 61:436–440, 1990Google Scholar
  52. 52.
    Baak JPA, van Dop H, Kurver PHJ, Hermans J: The value of morphometry to classical prognosticators in breast cancer. Cancer 56:374–382, 1985Google Scholar
  53. 53.
    Bryan RM, Mercer RJ, Bennett RC, Rennie GC: Prognostic factors in breast cancer and the development of a prognostic index. Breast J Surg 73:267–271, 1986Google Scholar
  54. 54.
    Jones M, Benson EA: Analysis of long-term prognostic factors in breast cancer. Nottingham International Breast Cancer Meeting, September, 1992Google Scholar
  55. 55.
    Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham L, Deutsch M, Montague E, Margolese R, Foster R: Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674–681, 1985Google Scholar
  56. 56.
    Williams MR, Hinton CP, Todd JH, Morgan DAL, Elston CW, Blamey RW: The prediction of local or regional recurrence after simple mastectomy for operable breast cancer. Breast J Surg 72:721–723, 1985Google Scholar
  57. 57.
    Morgan DAL, Galea MH, Berridge J, Blamey RW, Elston CW, Ellis IO: Post mastectomy radiotherapy in patients at high risk of loco-regional recurrence: A randomized trial. Nottingham International Breast Cancer Meeting, September, 1992Google Scholar
  58. 58.
    Veronesi U, Costa A, Saccozzi R: Surgical technique of breast quadrantectomy and axillary dissection.In Strombeck JO, Rosato FE (eds) Surgery of the Breast. Diagnosis and Treatment of Breast Disease. Thieme Verlag, Stuttgart, 1986, pp 127–131Google Scholar
  59. 59.
    O'Brien DP, Horgan DG, Gough DB, Shehill R, Grimes H, Given HF: CA 15-3: A reliable indicator of metastatic bone disease in breast cancer patients. Ann Roy Coll Surg Engl 74:9–12, 1992Google Scholar

Copyright information

© Kluwer Academic Publishers 1992

Authors and Affiliations

  • Marcus H. Galea
    • 1
  • Roger W. Blamey
    • 1
  • Christopher E. Elston
    • 1
  • Ian O. Ellis
    • 1
  1. 1.Nottingham City HospitalNottinghamU.K.

Personalised recommendations